Akanda Corp. (AKAN)

2.3950 +0.0050 (+0.21%) As of 01:19PM EDT. Market open.

Akanda Corp.

1a, 1b Learoyd Road
New Romney TN28 8XU
United Kingdom
44 20 3488 9514
https://www.akandacorp.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Ms. Katharyn Field	Interim CEO & Executive Director	111.97k	N/A	1983
Dr. Gurcharn Deol B.A., M.A., Ph.D.	Chief Financial Officer	45.43k	N/A	1968
Mr. Thomas Flow	Chief Operating Officer	N/A	N/A	1978

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis-based products for medicinal use worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.

Corporate Governance

Akanda Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.